Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for vascular lesion reduction in adults with type 1 diabetes
NL-OMON43685Phase 3Active, not recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetes mellitus type 1 (T1D) comparing Metformin add-on with Placebo add-on (2 arms). Primary endpoint: Progression of averaged mean far wall common carotid artery intima-media thickness. Started Aug 2012; status: active, not recruiting.
02
Drugs
metformin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on NL-OMON43685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43685.